test

Steve Giordano

@Casdin Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$1.5BTotal holdings35
Assets growth rate14.98%Assets growth rate (2-Q avg)5.98%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Casdin Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 35 positions.

Assets under management

The assets under management (AUM) of Casdin Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.5B in assets, with a quarterly growth rate of 14.98% and a 2-quarter average growth rate of 5.98%. The portfolio is managed by Steve Giordano, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
LABStandard Biotools Inc
Recent Activity
Increased 11.41%
9.17%
$137.522M
71.255M shares@ $1.94 avg price
ILMNIllumina Inc
Recent Activity
Increased 56.25%
6.53%
$97.808M
750,000 shares@ $130.41 avg price
RLAYRelay Therapeutics Inc
Recent Activity
Increased 9.5%
4.37%
$65.498M
9.251M shares@ $7.09 avg price
CDXSCodexis Inc
Recent Activity
Increased 305%
1.67%
$24.948M
8.1M shares@ $3.08 avg price
VERVVerve Therapeutics Inc
Recent Activity
Increased 30.62%
1.29%
$19.339M
3.996M shares@ $4.85 avg price
BEAMBeam Therapeutics Inc
Recent Activity
Increased 14.82%
1.27%
$18.988M
775,000 shares@ $24.5 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 43.75%
0.83%
$12.432M
1.15M shares@ $10.81 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 216.67%
0.61%
$9.144M
475,000 shares@ $19.25 avg price
GHGuardant Health Inc
Recent Activity
Increased 250%
0.54%
$8.029M
350,000 shares@ $22.94 avg price
IPSCCentury Therapeutics Inc
Recent Activity
Increased 0.19%
0.37%
$5.493M
3.212M shares@ $1.71 avg price